Total Payments
$540.30
2024 Payments
$96.73
Companies
10
Transactions
18
Medicare Patients
1,707
Medicare Billing
$102,612
Payment Breakdown by Category
Food & Beverage$540.30 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $540.30 | 18 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $197.92 | 7 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $116.60 | 2 | $0 (2021) |
| Gilead Sciences, Inc. | $74.59 | 1 | $0 (2021) |
| Vifor Pharma, Inc. | $29.23 | 1 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $27.96 | 1 | $0 (2023) |
| Lilly USA, LLC | $27.25 | 2 | $0 (2021) |
| PFIZER INC. | $20.51 | 1 | $0 (2024) |
| Novo Nordisk Inc | $16.19 | 1 | $0 (2023) |
| Amgen Inc. | $15.19 | 1 | $0 (2023) |
| Biogen, Inc. | $14.86 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $96.73 | 4 | ABBVIE INC. ($46.99) |
| 2023 | $59.34 | 3 | Janssen Pharmaceuticals, Inc ($27.96) |
| 2022 | $28.23 | 2 | Biogen, Inc. ($14.86) |
| 2021 | $356.00 | 9 | AbbVie Inc. ($137.56) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/15/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 07/24/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $29.23 | General |
| Category: Hyperkalemia | ||||||
| 01/12/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $30.18 | General |
| Category: NEUROSCIENCE | ||||||
| 11/29/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $27.96 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/06/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Inflammation | ||||||
| 06/07/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Diabetes | ||||||
| 03/29/2022 | Biogen, Inc. | ADUHELM (Biological) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: Neurology | ||||||
| 02/25/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: NEUROSCIENCE | ||||||
| 11/03/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $96.43 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $11.31 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: NEUROSCIENCE | ||||||
| 06/21/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: NEUROSCIENCE | ||||||
| 06/16/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $74.59 | General |
| 05/13/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $11.81 | General |
| Category: Diabetes | ||||||
| 05/05/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Respiratory | ||||||
| 04/19/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Diabetes | ||||||
| 04/13/2021 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $98.83 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 618 | 633 | $133,318 | $35,777 |
| 2022 | 12 | 510 | 555 | $76,334 | $29,033 |
| 2021 | 8 | 350 | 366 | $134,557 | $25,195 |
| 2020 | 10 | 229 | 254 | $99,098 | $12,607 |
Total Patients
1,707
Total Services
1,808
Medicare Billing
$102,612
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 291 | 304 | $58,672 | $23,032 | 39.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 38 | 38 | $11,096 | $3,417 | 30.8% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 77 | 78 | $11,700 | $3,200 | 27.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 35 | $4,620 | $1,595 | 34.5% |
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 11 | 12 | $19,228 | $1,390 | 7.2% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 20 | 20 | $21,713 | $1,360 | 6.3% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 33 | 33 | $2,475 | $609.12 | 24.6% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 13 | 13 | $975.00 | $450.06 | 46.2% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 26 | 26 | $780.00 | $406.16 | 52.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 50 | 50 | $800.00 | $110.00 | 13.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 12 | 12 | $660.00 | $105.27 | 16.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 12 | $600.00 | $103.29 | 17.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 248 | 265 | $43,192 | $20,194 | 46.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 36 | 36 | $8,961 | $3,244 | 36.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 38 | 40 | $4,600 | $2,329 | 50.6% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 38 | 39 | $5,850 | $1,187 | 20.3% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 15 | 15 | $8,493 | $635.28 | 7.5% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 26 | 26 | $1,950 | $586.15 | 30.1% |
| 90714 | Diphtheria and tetanus vaccine (7 years or older) | Office | 2022 | 12 | 12 | $675.00 | $259.64 | 38.5% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 11 | 11 | $330.00 | $179.01 | 54.2% |
| 90471 | Administration of vaccine | Office | 2022 | 13 | 13 | $585.00 | $149.30 | 25.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 15 | 17 | $850.00 | $148.05 | 17.4% |
| 81003 | Automated urinalysis test | Office | 2022 | 46 | 49 | $784.00 | $108.49 | 13.8% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2022 | 12 | 32 | $64.00 | $12.66 | 19.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 158 | 166 | $26,560 | $13,761 | 51.8% |
About Ganna Spektor, PA
Ganna Spektor, PA is a Medical healthcare provider based in Virginia Beach, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2011. The National Provider Identifier (NPI) number assigned to this provider is 1538457403.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ganna Spektor, PA has received a total of $540.30 in payments from pharmaceutical and medical device companies, with $96.73 received in 2024. These payments were reported across 18 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($540.30).
As a Medicare-enrolled provider, Spektor has provided services to 1,707 Medicare beneficiaries, totaling 1,808 services with total Medicare billing of $102,612. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical
- Location Virginia Beach, VA
- Active Since 07/13/2011
- Last Updated 04/21/2021
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1538457403
Products in Payments
- HUMIRA (Biological) $96.43
- UBRELVY (Drug) $60.00
- QULIPTA (Drug) $41.49
- Veltassa (Drug) $29.23
- XARELTO (Drug) $27.96
- TRULICITY (Drug) $27.25
- PAXLOVID (Drug) $20.51
- BREZTRI (Drug) $17.77
- Ozempic (Drug) $16.19
- Otezla (Drug) $15.19
- ADUHELM (Biological) $14.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Doctors in Virginia Beach
Allison Boyd, Pa-C, PA-C
Medical — Payments: $111,983
Medical $111,983
Juliette Beristain, Pa-C, PA-C
Medical — Payments: $33,772
Medical $33,772
Lisa Deafenbaugh, P.a, P.A
Medical — Payments: $7,908
Medical $7,908
Yekaterina Jones
Medical — Payments: $7,794
Medical $7,794
Mrs. Martha Stoops
Medical — Payments: $5,239
Medical $5,239
Kristin Curry, Pa, PA
Medical — Payments: $4,501
Medical $4,501